Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function.
Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function.
复制标题
DOI:
10.5588/ijtld.20.0906
复制
发表时间:
2021-04-01
期刊:
影响因子:
--
通讯作者:
Mortimer K
中科院分区:
文献类型:
--
作者:
Allwood BW;Stolbrink M;Baines N;Louw E;Wademan DT;Lupton-Smith A;Nel S;Maree D;Mpagama S;Osman M;Marx FM;Hoddinott G;Lesosky M;Rylance J;Mortimer K
Persistent respiratory symptoms and lung function deficits are common after patients with TB. We aimed to define the burden of post-TB lung disease (PTLD) and assess associations between symptoms and impairment in two high TB incidence communities. This was a cross-sectional survey of adults in Cape Town, South Africa who completed TB treatment 1–5 years previously. Questionnaires, spirometry and 6-minute walking distance (6MWD) were used to assess relationships between outcome measures and associated factors. Of the 145 participants recruited (mean age: 42 years, range: 18–75; 55 [38%] women), 55 (38%) had airflow obstruction and 84 (58%) had low forced vital capacity (FVC); the mean 6MWD was 463 m (range: 240–723). Respiratory symptoms were common: chronic cough (n = 27, 19%), wheeze (n = 61, 42%) and dyspnoea (modified MRC dyspnoea score 3 or 4: n = 36, 25%). There was poor correlation between FVC or obstruction and 6MWD. Only low body mass index showed consistent association with outcomes on multivariable analyses. Only 19 (13%) participants had a diagnosis of respiratory disease, and 16 (11%) currently received inhalers. There was substantial burden of symptoms and physiological impairment in this “cured” population, but poor correlation between objective outcome measures, highlighting deficits in our understanding of PTLD.